Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

por Zajecka, John M, Stanford, Arielle D, Memisoglu, Asli, Martin, William F, Pathak, Sanjeev
Publicado 2019

GABA level, gamma oscillation, and working memory performance in schizophrenia

por Chen, Chi-Ming A., Stanford, Arielle D., Mao, Xiangling, Abi-Dargham, Anissa, Shungu, Dikoma C., Lisanby, Sarah H., Schroeder, Charles E., Kegeles, Lawrence S.
Publicado 2014

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study

por Correll, Christoph U, Stein, Evan, Graham, Christine, DiPetrillo, Lauren, Akerman, Sarah, Stanford, Arielle D, Jiang, Ying, Yagoda, Sergey, McDonnell, David, Hopkinson, Craig
Publicado 2022

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

por Thase, Michael E., Stanford, Arielle D., Memisoglu, Asli, Martin, William, Claxton, Amy, Bodkin, J. Alexander, Trivedi, Madhukar H., Fava, Maurizio, Yu, Miao, Pathak, Sanjeev
Publicado 2019

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

por Fava, Maurizio, Thase, Michael E., Trivedi, Madhukar H., Ehrich, Elliot, Martin, William F., Memisoglu, Asli, Nangia, Narinder, Stanford, Arielle D., Yu, Miao, Pathak, Sanjeev
Publicado 2018

Using diffusion tensor imaging to identify corticospinal tract projection patterns in children with unilateral spastic cerebral palsy

por Kuo, Hsing‐Ching, Ferre, Claudio L, Carmel, Jason B, Gowatsky, Jaimie L, Stanford, Arielle D, Rowny, Stefan B, Lisanby, Sarah H, Gordon, Andrew M, Friel, Kathleen M
Publicado 2016